Analyte monitoring device and methods of use

  • US 8,409,131 B2
  • Filed: 03/07/2007
  • Issued: 04/02/2013
  • Est. Priority Date: 04/30/1998
  • Status: Expired due to Term
  • ×
    • Pin Icon | RPX Insight
    • Pin
First Claim
Patent Images

1. An integrated therapy management device, comprising:

  • a housing comprising;

    a receiver unit configured to receive one or more signals related to an analyte level from an analyte sensor;

    a data controller in communication with the receiver unit and configured to process the one or more signals related to the analyte level to determine a dose of a desired medicant; and

    a drug administration system in communication with the data controller to deliver the dose of the desired medicant, the drug administration system being part of a drug delivery system that is configured to determine a drug sensitivity feedback based on the one or more signals related to the analyte level; and

    a display coupled to the housing and configured to display data related to one or more of the determined dose of the desired medicant, the delivered dose of the desired medicant, or the analyte level;

    wherein the data controller, the receiver unit and the drug administration system are integrated as a single unit in the housing;

    wherein the data controller is configured to tag the one or more signals which are related to an episode of hyperglycemic condition or hypoglycemic condition for use in a data analysis of the episode of hyperglycemic condition or hypoglycemic condition;

    wherein the data controller is trainable such that the data controller is configured to analyze the tagged data associated with the episode of hyperglycemic condition or hypoglycemic condition to determine one or more patterns associated with the one or more of the hyperglycemic or hypoglycemic conditions, to determine the one or more patterns in response to the delivered medicant and the one or more signals related to the analyte level, and to provide a drug administration protocol based on the determined one or more patterns in response to the delivered medicant and the one or more signals related to the analyte level; and

    furtherwherein the drug administration system is configured to deliver a modified dose of desired medicant based upon the one or more patterns of the one or more of the hyperglycemic or hypoglycemic conditions determined by the data controller.

View all claims